Laboratorios Farmaceuticos Rovi, S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LABFF research report →
About the company
Laboratorios Farmaceuticos Rovi, S. A. is a pharmaceutical firm actively involved in the discovery, creation, manufacturing, and commercialization of medicinal products.
- CEO
- Juan Lopez-Belmonte Encina
- IPO
- 2021
- Employees
- 2,197
- HQ
- Madrid, ES
Price Chart
- Market Cap
- $4.63B
- P/E
- 22.14
- P/S
- 3.93
- P/B
- 4.32
- EV/EBITDA
- 14.64
- Div Yield
- 1.64%
- Gross Margin
- 63.23%
- Op Margin
- 22.81%
- Net Margin
- 17.79%
- ROE
- 20.89%
- ROIC
- 15.99%
- Revenue
- $743.20M · -2.69%
- Net Income
- $140.39M · 2.56%
- EPS
- $2.75 · 3.00%
- Op Income
- $173.08M
- FCF YoY
- 57.93%
- 52W High
- $90.61
- 52W Low
- $90.61
- 50D MA
- $90.61
- 200D MA
- $90.61
- Beta
- 0.22
- Avg Volume
- 60.4
Get TickerSpark's AI analysis on LABFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LABFF coverage
Recent articles, reports, and earnings notes.
No research on LABFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LABFF report →Similar companies
Peers in the same neighborhood.